Israeli attacks leave at least 20 dead in Gaza
By Rodrigo Santos Andrade
While there was an explosion in the use of GLP-1 drugs in 2025, two pharmaceutical giants are preparing to debut their oral options in 2026. The pills could transform the industry, but how do they compare to those injected drugs and what will they cost? NBC’s Liz Kreutz reports in this week’s Sunday Focus.